Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Jan M. Keppel Hesselink

Department of Molecular Pharmacology, University of Witten/Herdecke, Germany, and Institute for neuropathic pain, The Netherlands

Biography

Jan M. Keppel Hesselink, MD, MSc, PhD received his MSc in biology (cum laude) at the university of Utrecht; his degree in medicine, MD in Utrecht, his PhD (thesis on Parkinson's disease) at the university of Nijmegen, NL. In 1996 he was appointed professor of molecular pharmacology at the university of Witten/Herdecke (Germany). He became a member of the British association of psychopharmacology (MBAP) and in the same period he was elected as Fellow of the Pharmaceutical Faculty in Medicine (FFPM) in the UK. He worked several years at Bayer AG in Germany as VP CNS and business head CNS.
Publications

Primumnon Nocere: Supplements As Analgesics, A Neglected Area

Jan M. Keppel Hesselink

Editorial: J Pain Relief 2013, 2:e116

DOI: 10.4172/2167-0846.1000e116

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF

Relevant Topics
Top